Can we protect workers from developing the adverse respiratory effects of isocyanate exposure?

Occupational Medicine - State of the Art Reviews

Volumn 15, Issue 2, 2000, Pages 399-409

  Dedhia, Harakh V ^b   Rando, Roy J ^b   Banks, Daniel E ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCYANIC ACID DERIVATIVE;

ASTHMA; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; ENVIRONMENTAL MONITORING; FEMALE; HUMAN; MALE; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; REVIEW; SENSITIVITY AND SPECIFICITY;

ASTHMA; CLINICAL TRIALS; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; ISOCYANATES; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; SENSITIVITY AND SPECIFICITY;

EID: 33748995426     PISSN: 0885114X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Adams WGF: Long-term effects on the health of men engaged in the manufacture of tolylene diisocyanate. Br J Ind Med 32:72-78, 1975.
2. Banks DE, Sastre J, Butcher BT, et al: Role of inhalation challenge testing in the diagnosis of isocyanate-induced asthma. Chest 95:414-423, 1989.
3. Banks DE, Rando RJ, Barkman HW Jr: Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposures. Chest 97:121-125, 1990.
4. Belin L, Wass U, Audunsson G, et al: Amines: Possible causative agents in the development of bronchial hyperreactivity in workers manufacturing polyurethanes from isocyanates. Br J Ind Med 40:251-257. 1983.
5. Bernstein DI, Korbee L, Stauder T, et al: The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to isocyanates. J Allergy Clin Immunol 92:387-396, 1993.
6. Bignon JS, Aron Y, Ju LY, et al: HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med 149:71-75, 1994.
7. Butcher BT, Jones RN, O'Neil CE, et al: Longitudinal study of workers employed in the manufacture of toluene diisocyanate. Am Rev Respir Dis 116:411-422, 1997.
8. Butcher BT, Banks DE: Immunologic and clinical features of occupational agents attributable to small molecular weight agents. Immunol Allergy Clin North Am 12:329-345, 1992.
9. Candura F, Moscato G: Do amines induce occupational asthma in workers manufacturing polyurethane foams? Br J Ind Med 41:552-553, 1984.
10. Clark RL, Bugler J, McDermott M, et al: An epidemiology study of lung function changes of toluene diisocyanate foam workers in the United Kingdom. Int Arch Occup Environ Health 71:169-179, 1998.
11. Diem JE, Jones RN, Hendrick DJ, et al: Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant. Am Rev Respir Dis 126:420-428, 1982.
12. Fabbri LM, Daniele D, Criscioli S, et al: Fatal asthma in a subject sensitized to toluene diisocyanate. Am Rev Respir Dis 137:1494-1498, 1988.
13. Gee JB, Morgan WKC: A 10-year follow-up study of a group of workers exposed to isocyanates. J Occup Med 27:15-18, 1985.
14. Hathaway JA, DeWilde A, Shepperly DC, et al: Evaluation of pulmonary function in workers exposed to hexamethylene diisocyanate. J Occup Environ Med 41:378-383, 1999.
15. Jajosky RA, Harrison R, Reinisch F, et al: Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments - California, Massachusetts, Michigan, and New Jersey, 1993-1995. MMWR CDC Surveill Summ 48:1-20, 1999.
16. Jones RN, Rando RJ, Glindmeyer HW, et al: Abnormal lung function in polyurethane foam producers: Weak relationship to toluene diisocyanate exposures. Am Rev Respir Dis 146:871-877, 1992.
17. Karol MH, Tollerud DJ, Campbell TP, et al: Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge. Am J Respir Crit Care Med 149:611-615, 1994.
18. Kogevinas M, Anto JM, Sunyer J, et al: Occupational asthma in Europe and other industrialised areas: A population-based study. European Community Respiratory Health Survey Study Group. Lancet 22;353(9166):1750-1754, 1999.
19. Lemiere C, Cartier A, Dolovich J, et al: Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med 154:329-333, 1996.
20. Liss GM, Tarlo SM, Banks D, et al: Preliminary report of mortality among workers compensated for work- related asthma. Am J Ind Med 35:465-471, 1999.
21. Mapp CE, DiGiacomo CR, Zedda L, et al: Isocyanate-induced asthma: A review of 165 cases studied in 1983-1985. J Allergy Clin Immunol 77:17, 1986 (abstract).
22. McKerrow CB, Davies HJ, Parry Jones A: Symptoms and lung function following acute and chronic exposure to tolylene diisocyanate. Proc Roy Soc Med 63:376-378, 1970.
23. Moller DR, Brooks SM, McKay RT, et al: Chronic asthma due to toluene diisocyanate. Chest 90:494-499, 1986.
24. Musk AW, Peters JM, DiBerardinis L, et al: Absence of respiratory effects in subjects exposed to low concentrations of TDI and MDI. J Occup Med 24:746-750, 1982.
25. Nordman H, Karjalainen A, Keskinen H: Incidence of occupational asthma: A comparison by reporting systems. Am J Ind Med (Suppl) 1:130-133, 1999.
26. Olsen GW, Shellenberger R, Bodner KM, et al: An epidemiologic investigation of forced expiratory volume at 1 second and respiratory symptoms among employees of a toluene diisocyanate production plant. J Occup Environ Med 31:664-667, 1989.
27. Omae K, Higashi T, Nakadate T, et al: Four-year follow-up of effects of toluene diisocyanate exposure on the respiratory system in polyurethane foam manufacturing workers. Int Arch Occup Environ Health 63:565-569, 1992.
28. Parkes HG: Isocyanates in industry: Environmental control. Proc R Soc Med 63:368-372, 1970.
29. Peters JM, Murphy RLH, Pagnatto LD, et al: Acute respiratory effects in workers exposed to low levels of toluene diisocyanate. Arch Environ Health 16:642-647, 1968.
30. Peters JM, Murphy RLH, Ferris BG Jr: Ventilatory function in workers exposed to low levels of toluene diisocyanate: A 6-month follow-up. Brit J Ind Med 26:115-120, 1969.
31. Peters JM: Studies of isocyanate toxicity. Cumulative pulmonary effects in workers exposed to tolylene diisocyanate. Proc R Soc Med 63:372-375, 1970.
32. Peters JM, Murphy RLH, Pagnatto LD, et al: Respiratory impairment in workers exposed to safe levels of toluene diisocyanate. Arch Environ Health 20:364-367, 1970.
33. Pham QT, Cavelier C, Mereau P, et al: Isocyanates and respiratory function: A study of workers producing polyurethane foam molding. Ann Occup Hyg 21:121-129, 1978.
34. Reilly MJ, Rosenman KD, Watt FC, et al: Surveillance for occupational asthma - Michigan and New Jersey, 1988-1992. MMWR CDC Surveill Summ 43:9-17, 1994.
35. Ross DJ, Keynes HL, McDonald JC: SWORD '97: surveillance of work-related and occupational respiratory disease in the UK. Occup Med (Lond) 48:481-485, 1998.
36. Tansar AR, Bourke MP, Blandford AG: Isocyanate asthma: Respiratory symptoms caused by diphenyl methane diisocyanate. Thorax 28:596-600, 1973.
37. Tarlo SM, Liss GM, Dias C, et al: Assessment of the relationship between isocyanate exposure levels and occupational asthma. Am J Ind Med 32:517-521, 1997.
38. Tarlo SM, Banks D, Liss G, Broder I: Outcome determinants for isocyanate-induced occupational asthma among compensation claimants. Occup Environ Med 54:756-761, 1997.
39. Wegman DH, Pagnoto LD, Fine LJ, et al: A dose response relationship in TDI workers. J Occup Med 16:258-260, 1974.
40. Wegman DH, Peters JM, Pagnotto L, et al: Chronic pulmonary function loss from exposure to toluene diisocyanate. Br J Ind Med 34:196-200, 1977.
41. Venables KM, Dally MB, Nunn AJ, et al: Smoking and occupational allergy in workers in a platinum refinery. Br Med J 299:939-942, 1989.